ANUH PHARMA LIMITED

215.34
-2.34
(-1.08%)
Market Cap (₹ Cr.)
₹1,091
52 Week High
245.70
Book Value
₹
52 Week Low
208.16
PE Ratio
18.43
PB Ratio
3.59
PE for Sector
37.26
PB for Sector
4.92
ROE
%
ROCE
26.85 %
Dividend Yield
1.15 %
EPS
₹
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
23.52 %
Net Income Growth
66.02 %
Cash Flow Change
-76.01 %
ROE
37.47 %
ROCE
37.20 %
EBITDA Margin (Avg.)
23.05 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
72
87
90
79
71
50
51
55
57
55
58
65
69
81
89
71
84
86
75
77
73
127
116
101
99
119
111
132
130
117
117
141
158
165
152
176
167
142
169
Expenses
63
75
78
71
64
45
43
48
49
47
53
58
63
73
79
64
75
77
70
67
70
101
102
92
93
109
96
120
115
105
102
126
143
148
132
148
145
127
149
EBITDA
9
12
12
8
8
6
7
6
8
8
5
7
5
8
10
8
9
9
5
10
3
27
14
9
6
10
14
13
15
12
15
15
15
17
20
28
22
14
20
Operating Profit %
11 %
12 %
13 %
9 %
9 %
9 %
11 %
10 %
11 %
9 %
4 %
9 %
6 %
9 %
10 %
9 %
9 %
9 %
6 %
11 %
3 %
19 %
10 %
7 %
4 %
7 %
11 %
9 %
11 %
10 %
12 %
9 %
9 %
9 %
12 %
14 %
12 %
8 %
10 %
Depreciation
2
1
1
1
1
1
0
1
1
0
0
0
1
0
0
0
1
1
1
1
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
0
0
0
1
-0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax
7
12
12
8
7
5
7
6
8
8
4
7
5
8
10
7
8
8
4
8
-2
22
10
5
2
7
11
9
12
10
13
12
13
15
18
25
20
12
18
Tax
2
4
4
3
2
1
2
2
3
1
2
2
2
2
3
2
2
2
1
2
-2
6
3
0
1
2
3
2
4
3
3
3
4
4
4
6
5
3
4
Net Profit
5
8
7
5
5
4
5
4
5
6
2
5
3
6
7
5
5
6
3
6
-1
17
7
4
1
6
9
7
9
7
10
9
10
12
14
19
15
10
15
EPS in ₹
5.97
9.61
2.97
2.08
2.05
1.89
1.94
1.74
2.10
2.50
0.82
1.97
1.30
2.27
2.78
2.15
2.12
2.34
0.60
1.27
-0.18
3.34
1.32
0.83
0.18
1.12
1.72
1.49
1.78
1.46
1.98
1.86
1.92
2.35
2.76
3.81
3.06
1.90
3.00

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
168
193
189
209
240
326
333
347
405
446
Fixed Assets
10
18
17
17
21
84
71
61
53
49
Current Assets
144
151
138
154
152
223
238
259
308
336
Capital Work in Progress
0
0
0
6
34
0
0
0
0
1
Investments
29
22
70
66
39
80
31
43
91
97
Other Assets
129
152
101
120
147
163
230
243
261
300
Total Liabilities
168
193
189
209
240
326
333
347
405
446
Current Liabilities
67
73
47
59
75
163
140
131
161
153
Non Current Liabilities
1
1
1
1
1
2
3
3
2
2
Total Equity
101
119
141
150
165
162
191
214
241
291
Reserve & Surplus
97
107
128
137
152
150
166
189
216
266
Share Capital
4
13
13
13
13
13
25
25
25
25

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-1
2
2
-1
4
-5
0
2
-2
5
Investing Activities
-12
-5
-20
2
3
-77
52
-8
-44
1
Operating Activities
19
17
26
2
7
49
-19
29
54
13
Financing Activities
-8
-9
-4
-5
-7
22
-33
-20
-12
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
70.47 %
70.43 %
70.43 %
70.45 %
70.44 %
70.59 %
70.59 %
70.59 %
70.59 %
70.59 %
70.59 %
69.94 %
69.92 %
69.92 %
69.92 %
69.92 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.03 %
0.03 %
0.02 %
0.02 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.11 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.04 %
26.27 %
26.33 %
26.26 %
26.16 %
26.18 %
26.12 %
26.00 %
25.94 %
25.68 %
25.79 %
26.14 %
26.20 %
26.30 %
26.27 %
26.12 %

Dividend History

No dividends have been distributed by the company in the past 10 years

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,841.35 4,36,439.00 38.90 49,887.20 12.06 9,648 27.34 59.05
5,886.75 1,53,503.20 83.63 8,184.00 0.89 1,600 46.55 48.08
1,490.55 1,19,175.70 25.82 26,520.70 14.17 4,155 12.95 50.71
2,916.65 1,16,611.50 56.78 10,615.60 19.57 1,942 28.89 63.62
1,355.15 1,12,712.30 21.12 28,905.40 12.36 5,578 -9.47 71.05
2,182.10 98,956.70 37.66 20,141.50 19.94 1,936 73.53 60.05
957.65 97,081.50 22.69 19,831.50 13.82 3,831 14.57 42.02
1,256.25 73,323.30 20.28 29,559.20 17.55 3,169 8.66 48.45
5,408.60 64,640.40 29.75 12,978.40 9.84 1,812 14.16 41.69
1,541.45 43,338.50 - 12,653.10 6.58 -1,831 675.49 48.19

Corporate Action

Technical Indicators

RSI(14)
Oversold
0.00
ATR(14)
Volatile
0.00
STOCH(9,6)
0.00
STOCH RSI(14)
Oversold
0.00
MACD(12,26)
Bearish
0.00
ADX(14)
Weak Trend
0.00
UO(9)
Bullish
0.00
ROC(12)
0.00
WillR(14)
Overbought
0.00